/Sponsor / Executive Profile

Kyle P. Bransfield

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Kyle P. Bransfield has been a prominent figure in the SPAC landscape, serving as the Chief Executive Officer and a director since December 2017. He is currently the President, Chief Executive Officer, and a director of Union Finance Corp, where he has played a pivotal role in the company's strategic direction and operations. In addition to his leadership at Union Finance Corp, Mr. Bransfield is also the Chief Financial Officer and a director of Union Acquisition Corp. II, further showcasing his extensive experience in the SPAC sector. His involvement in these organizations highlights his expertise in financial management and corporate governance. Mr. Bransfield is a partner at Atlantic-Pacific Capital, where he contributes to the firm's investment strategies and client relations. His multifaceted roles across various SPACs and financial institutions underscore his significant influence and commitment to the growth and development of the SPAC market.

Total Capital Deployed

$376,000,000

Active / Searching Capital:
-

Transaction Volume

6 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Associates

Top Sectors

  • Pharmaceuticals2 Deals
  • Agricultural Biotechnology1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
MLEC
LightJump Acquisition Corporation
closed
-
$11.50
-Jan 2023Done
325.0M
GeneralNomura Securities International, Inc.
PROC
Procaps
closed
-
$10.00
1/1Nov 2021Done
1.1B
Pharmaceuticals
LJAQ
LightJump Acquisition Corporation
closed
100.0M
$10.00
1/2Dec 2020Done
377.3M
GeneralEarlyBird Capital, Inc.
LATN
Union Acquisition Corp. II
closed
175.0M
$10.00
1/1Sep 2019Done
1.1B
PharmaceuticalsCantor Fitzgerald & Co.
MBII
Marrone Bio Innovations, Inc.
closed
-
-
-May 2019Done-General
Bioceres S.A.
LTN
Union Acquisition Corp.
announced
101.0M
$10.00
1/1Jan 2018--Agricultural BiotechnologyLadenburg Thalmann & Co., Inc.